Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

4774 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-21

Study Completion Date

2017-04-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus

NCT00217061

Diabetes Mellitus Dyslipidemia Hypercholesterolemia +1 more

COMPLETED PHASE3

Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients

NCT02001883

Coronary Artery Disease

UNKNOWN PHASE4

To Investigate the Role of Upstream High Dose Statin in STEMI

NCT01050348

Acute Myocardial Infarction

COMPLETED PHASE4

Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

NCT06922994

Arrhythmogenic Cardiomyopathy

RECRUITING PHASE2

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

NCT02579499

Coronary Artery Diseasse

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Strong evidence indicates that statin medications can reduce the risk of CVD and for those with CVD statins have been shown to reduce mortality. Despite this evidence, statins are under-prescribed. In this study, the investigators will test the effectiveness of nudges targeted to physicians using active choice and social comparisons feedback to increasing the rate at which statin medications are prescribed to patients eligible based on national practice guidelines.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

No intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Active choice

Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.

Group Type EXPERIMENTAL

Active choice

Intervention Type BEHAVIORAL

Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin

Active choice with social comparison feedback

Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers

Group Type EXPERIMENTAL

Active choice

Intervention Type BEHAVIORAL

Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin

Social comparison feedback

Intervention Type BEHAVIORAL

Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active choice

Statin options are framed to physicians as an active choice to prescribe or not prescribe a statin

Intervention Type BEHAVIORAL

Social comparison feedback

Statin prescribing rates are communicated to physicians and along with how their performance compares to their peers

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has a primary care physician at University of Pennsylvania Health System
* Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record

Exclusion Criteria

* Patient has an allergy or adverse reaction to statins documented in the electronic health record
* Patient has glomerular filtration rate less than 30 mL/min
* Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin

Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes